Clinical Validity of Serum Antibodies to SARS-CoV-2

G. Caturegli, J. Materi, Brittney Howard, P. Caturegli

Annals of Internal Medicine, 2020

Serum antibodies develop upon infection with SARS-CoV-2 and are currently used to stratify donors of convalescent plasma and assess the prevalence of COVID-19. This study examines the use of serum antibodies to SARS-CoV-2 spike protein in the diagnosis of COVID-19.

Cited by 26 publications.

Field of study: Medicine

10.7326/M20-2889